The prognostic role of brain natriuretic peptides in hemodialysis patients

American Journal of Nephrology

Volumn 22, Issue 5-6, 2002, Pages 437-444

  Naganuma, Toshihide ^a   Sugimura, Kazunobu ^a   Wada, Seiji ^a   Yasumoto, Ryoji ^a   Sugimura, Takeshi ^a   Masuda, Chikayoshi ^a   Uchida, Junji ^a   Nakatani, Tatuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain natriuretic peptides; Cardiac mortality; Cardiovascular disease; Hemodialysis; Left ventricular hypertrophy; Volume overload

Indexed keywords

ALBUMIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HAZARD ASSESSMENT; HEART DEATH; HEART EJECTION FRACTION; HEART INDEX; HEART VENTRICLE; HEART VENTRICLE OVERLOAD; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; MUSCLE ATROPHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SURVIVAL;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RENAL DIALYSIS; STROKE VOLUME; SURVIVAL RATE;

EID: 0036976977     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065272     Document Type: Article

References (35)

1. Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
2. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, et al: Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-1412.
3. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
4. Magga J, Vuolteenaho O. Tokola H, Marttila M, Ruskoaho H: B-type natriuretic peptide: A myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Ann Med 1998;30(suppl 1):39-45.
5. Ishizaka Y, Yamamoto Y, Fukunaga T, Yokota N, Kida O, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T: Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 1994;24:461-472.
6. Ichikawa H, Nagake Y, Takahashi M, Nakazono H, Kawabata K, Ogura T, Makino H: Significance of atrial and brain natriuretic peptides in patients with diabetes mellitus undergoing hemodialysis. Clin Exp Nephrol 1997;1:41-50.
7. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F: Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 1995;44(suppl 1):S61-S64.
8. Lang CC, Choy AM, Henderson IS, Coutie WJ, Struthers AD: Effect of haemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure. Clin Sci (Lond) 1992;82:127-131.
9. Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grunert A: Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Investig 1994;72:430-434.
10. Kohse KP, Feifel K, Mayer Wehrstein R: Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol 1993;40:83-90.
11. Nitta K, Kawashima A, Yumura W, Naruse M, Oba T, Kabaya T, Nihei H: Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol 1998;18:411-415.
12. Saxenhofer H, Gnadinger MP, Weidmann P, Shaw S, Schohn D, Hess C, Uehlinger DE, Jahn H: Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Kidney Int 1987;32:554-561.
13. Shiota J, Kubota M, Hamada C, Koide H: Plasma atrial natriuretic peptide during hemodialysis with or without fluid removal. Nephron 1990;55:283-286.
14. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986;57:450-458.
15. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H: Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996;28:22-30.
16. Franz M, Woloszczuk W, Horl WH: N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Kidney Int 2000;58:374-383.
17. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara N, et al: Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34.
18. Sayama H, Nakamura Y, Saito N, Kinoshita M, Suda M: Relationship between left ventricular geometry and brain natriuretic peptide levels in elderly subjects. Gerontology 2000;46: 71-77.
19. Nishikimi T, Futoo Y, Tamano K, Takahashi M, Suzuki T, Minami J, Honda T, Uetake S, Asakawa H, Kobayashi N, Horinaka S, Ishimitsu T, Matsuoka H: Plasma brain natriuretic peptide levels in chronic hemodialysis patients: Influence of coronary artery disease. Am J Kidney Dis 2001;37:1201-1208.
20. Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Stancanelli B, Malatino LS: Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001;59:1559-1566.
21. London GM, Guérin AP, Marchais SJ: Pressure-overload cardiomyopathy in end-stage renal disease. Curr Opin Nephrol Hypertens 1999;8:179-186.
22. Wilkins MR, Redondo J, Brown LA: The natriuretic-peptide family. Lancet 1997;349:1307-1310.
23. Isotani H, Kameoka K, Sasaki I, Hida H, Kakutani S, Tasaki T: Plasma brain natriuretic peptide levels in normotensive type 2 diabetic patients without cardiac disease (letter). Diabetes Care 2000;23:859-860.
24. Grossman E, Messerli FH: Diabetic and hypertensive heart disease. Ann Intern Med 1996;125:304-310.
25. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-516.
26. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE: Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996;49:1428-1434.
27. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 1995;5:2024-2031.
28. Shinzato T, Nakai S, Akiba T, Yamazaki C, Sasaki R, Kitaoka T, Kubo K, Shinoda T, Kurokawa K, Marumo F, Sato T, Maeda K: Survival in long-term haemodialysis patients: Results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997;12:884-888.
29. Omland T, Aakvaag A, Bonarjee VV, Caidahl K, Lie RT, Nilsen DW, Sundsfjord JA, Dickstein K: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-1969.
30. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Cottini E, Malatino LS: Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:1508-1515.
31. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 1996;7:728-736.
32. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
33. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-476.
34. Silberberg JS, Barre PE, Prichard SS, Sniderman AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989;36:286-290.
35. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-192.